Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRADA: Candesartan and Metoprolol for Cardiac Protection in Breast Cancer
NCT01434134Phase 2Completed
- Start
- Sep 2011
- Primary completion
- Sep 2014
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of candesartan, metoprolol in heart failure (HF), left ventricular dysfunction. Started Sep 2011; status: completed.
02
Drugs
candesartanmetoprolol
03
Conditions
heart failure (HF)left ventricular dysfunction
Beyond the preview
Go deeper on NCT01434134.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01434134.